Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Kids' Risk for Chronic Conditions Higher When Mom Has RA

Published: Tue, 12 Dec 2017 18:06:17 EST
Clinicians should be aware that offspring of moms with RA may have higher risk for RA, thyroid disease, or epilepsy, researchers warn.
Medscape Medical News

Drug Deposited Directly Into the Brain Effective in Epilepsy

Published: Tue, 12 Dec 2017 15:59:51 EST
A microinfusion device that continuously delivers valproate directly to the brain is safe and effective in patients with severe, refractory focal epilepsy, early research shows.
Medscape Medical News

Smoking Cessation Treatment in Mental Illness Effective

Published: Tue, 12 Dec 2017 15:39:44 EST
Headway is being made in the treatment of tobacco dependence in psychiatric and substance abuse patients, owing to a better understanding of the safety and efficacy of therapeutic strategies.
Medscape Medical News

National Survey: About Half of Gastroenterologists Burnt Out

Published: Tue, 12 Dec 2017 15:37:56 EST
The level of burnout among gastroenterologists has 'serious implications' for the workforce, and needs to be taken as a 'wake-up call,' experts report.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Activating the hedgehog pathway protects mice from obesity

Published: Wed, 06 Dec 2017 19:53:03 +0000
Boosting a protein signaling pathway in the body known as "hedgehog" prevented weight gain in mice, a team from Washington University in St. Louis found. The method, which stops fat cells from growing larger, targets a common cause of obesity in adults.

Quebec's Amorchem sets up $44M+ life sciences VC

Published: Wed, 06 Dec 2017 15:57:10 +0000
With the launch of its $44.2 million life sciences venture capital fund, the AmorChem Group now has $86 million under management.

Amgen, Carmot ink backloaded $240M Parkinson’s pact

Published: Wed, 06 Dec 2017 14:11:26 +0000
Amgen has struck a deal with Carmot Therapeutics worth a potential $240 million. The alliance tasks Carmot with using its lead-identification technology to provide Amgen with a stream of prospects against conditions including Parkinson’s disease.

Biotech veteran Gilman is back, heading up next-gen CAR-T startup Obsidian

Published: Wed, 06 Dec 2017 13:31:38 +0000
Michael Gilman went into retirement when Bristol-Myers Squibb bought out his Padlock Therapeutics venture last year, but has made a comeback at the helm of a new company promising to transform cell and gene therapies.
Displaying results 21-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy